Clinical trial
COMparative Performance of General Purpose Models for Propofol And REmifentanil in Neurosurgical Patients Admitted to the Intensive Care Unit
NCT06584097 is registered in ClinicalTrials.gov with Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- COMparative Performance of General Purpose Models for Propofol And REmifentanil in Neurosurgical Patients Admitted to the Intensive Care Unit
- Lead sponsor
- Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- October 2, 2024
- Completion date
- December 31, 2026
- Enrollment
- 42 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
neurosurgical patients